Ireland - English - HPRA (Health Products Regulatory Authority)

support pharma, s.l. - marbofloxacin - solution for injection - 40 mg/ml - antibacterial - porcine

Germany - English - HMA (Heads of Medicines Agencies)

norbrook laboratories limited - marbofloxacin 0 % - injection - cattle - marbofloxacin

United States - English - NLM (National Library of Medicine)

dechra veterinary products llc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - indications and usage: marboquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. contraindications: marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

aspen veterinary resources®, ltd - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - delaquintm  chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

mwi - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - fluoroflox chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - marbofloxacin - solution for injection - 20 milligram(s)/millilitre - marbofloxacin - cats, cattle, dogs, pigs - antibacterial

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - marbofloxacin - oral tablet - marbofloxacin antibiotic active 100.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacillus spp. | beta-hemolytic streptococcus (not a or b | corynebacterium spp. | enterococcus faecalis | escherichia coli (e. coli) | infections of the skin | infections of the urinary tracts | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas aeruginosa | pseudomonas spp. | soft tissue infections | staphylococcus aureus | staphylococcus intermedius | streptococcus spp. | abscesses | anal sacculitis | bacterial canker | deep pyodermas | escherichia coli | fowl cholera | fungal | gingivitis | gram negative bacteria | gram positive bacteria | group d streptococcus | including b-lactamase producin | including secondary invaders | klebsiella spp. | not group a | not group b | post-parturient infections | proteus spp. | pseudomonas aeruginosa | pyoderma | seborrhoeic dermatitis | septicaemia | staphylococcus spp. | yeast

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - marbofloxacin - oral tablet - marbofloxacin antibiotic active 25.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacillus spp. | beta-hemolytic streptococcus (not a or b | corynebacterium spp. | enterococcus faecalis | escherichia coli (e. coli) | infections of the skin | infections of the urinary tracts | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas aeruginosa | pseudomonas spp. | soft tissue infections | staphylococcus aureus | staphylococcus intermedius | streptococcus spp. | abscesses | anal sacculitis | bacterial canker | deep pyodermas | escherichia coli | fowl cholera | fungal | gingivitis | gram negative bacteria | gram positive bacteria | group d streptococcus | including b-lactamase producin | including secondary invaders | klebsiella spp. | not group a | not group b | post-parturient infections | proteus spp. | pseudomonas aeruginosa | pyoderma | seborrhoeic dermatitis | septicaemia | staphylococcus spp. | yeast

Ireland - English - HPRA (Health Products Regulatory Authority)

emdoka - marbofloxacin - tablet - 20 mg/tablet - marbofloxacin - canine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

emdoka - marbofloxacin - tablet - 5 mg/tablet - marbofloxacin - canine, feline - antibacterial